Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingsong Qiu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
PNAS Nexus|December 1, 2025
Enhancing BeiDou/GNSS integrity with minmax optimizationJingsong Qiu, Ci Chen, Siyu Lei, et al.
Cellular and Molecular Neurobiology|December 4, 2024
TMEM16A Activation Inhibits Autophagy in Dorsal Root Ganglion Cells, Which is Associated with the p38 MAPK/mTOR PathwayShuyun Yang, Hui Shang, Yuruo Zhang, et al.
European Journal of Medicinal Chemistry|August 25, 2022
Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's diseaseWenjie Liu, Limeng Wu, Wenwu Liu, et al.
Journal of Medicinal Chemistry|July 23, 2024
Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer's DiseaseHuanhua Chen, Xudong Gao, Xinzhu Li, et al.
Archiv Der Pharmazie|November 27, 2023
Discovery of novel harmine derivatives as GSK-3β/DYRK1A dual inhibitors for Alzheimer's disease treatmentJingsong Qiu, Xiangling Feng, Huanhua Chen, et al.
Bioorganic Chemistry|May 4, 2025
UCP1-inspired mitochondrial uncouplers: Design, synthesis and thermogenic activity studiesHao Gong, Yiming Qi, Xinyi Wu, et al.
European Journal of Medicinal Chemistry|September 2, 2022
Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancerLimeng Wu, Wenjie Liu, Yaoguang Huang, et al.
European Journal of Medicinal Chemistry|July 21, 2025
Corrigendum to "Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer" [Eur. J. Med. Chem. 242 (2022): 114701]Limeng Wu, Wenjie Liu, Yaoguang Huang, et al.
Bioorganic Chemistry|December 25, 2024
Discovery of novel oxindole derivatives as TRPA1 antagonists with potent analgesic activity for pain treatmentYiming Qi, Hao Gong, Zhiya Wang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
PNAS Nexus|December 1, 2025
Enhancing BeiDou/GNSS integrity with minmax optimizationJingsong Qiu, Ci Chen, Siyu Lei, et al.
Cellular and Molecular Neurobiology|December 4, 2024
TMEM16A Activation Inhibits Autophagy in Dorsal Root Ganglion Cells, Which is Associated with the p38 MAPK/mTOR PathwayShuyun Yang, Hui Shang, Yuruo Zhang, et al.
European Journal of Medicinal Chemistry|August 25, 2022
Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's diseaseWenjie Liu, Limeng Wu, Wenwu Liu, et al.
Journal of Medicinal Chemistry|July 23, 2024
Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer's DiseaseHuanhua Chen, Xudong Gao, Xinzhu Li, et al.
Archiv Der Pharmazie|November 27, 2023
Discovery of novel harmine derivatives as GSK-3β/DYRK1A dual inhibitors for Alzheimer's disease treatmentJingsong Qiu, Xiangling Feng, Huanhua Chen, et al.
Bioorganic Chemistry|May 4, 2025
UCP1-inspired mitochondrial uncouplers: Design, synthesis and thermogenic activity studiesHao Gong, Yiming Qi, Xinyi Wu, et al.
European Journal of Medicinal Chemistry|September 2, 2022
Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancerLimeng Wu, Wenjie Liu, Yaoguang Huang, et al.
European Journal of Medicinal Chemistry|July 21, 2025
Corrigendum to "Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer" [Eur. J. Med. Chem. 242 (2022): 114701]Limeng Wu, Wenjie Liu, Yaoguang Huang, et al.
Bioorganic Chemistry|December 25, 2024
Discovery of novel oxindole derivatives as TRPA1 antagonists with potent analgesic activity for pain treatmentYiming Qi, Hao Gong, Zhiya Wang, et al.
Pageof 1